AAAAAA
Results:
1-11
|
Results: 11
Authors:
Hoffmann, S
Krause, T
van Geel, PP
Willenbrock, R
Pagel, I
Pinto, YM
Buikema, H
van Gilst, WH
Lindschau, C
Paul, M
Inagami, T
Ganten, D
Urata, H
Citation: S. Hoffmann et al., Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy, J MOL MED-J, 79(10), 2001, pp. 601-608
Authors:
Boonstra, AH
Gschwend, S
Kocks, MJA
Buikema, H
de Zeeuw, D
Navis, GJ
Citation: Ah. Boonstra et al., Does a low-salt diet exert a protective effect on endothelial function in normal rats?, J LA CL MED, 138(3), 2001, pp. 200-205
Authors:
Zeebregts, C
van den Dungen, J
Buikema, H
Tiebosch, A
van der Want, J
van Schilfgaarde, R
Citation: C. Zeebregts et al., Preservation of endothelial integrity and function in experimental vascular anastomosis with non-penetrating clips, BR J SURG, 88(9), 2001, pp. 1201-1208
Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS study)
Authors:
Oosterga, M
Voors, AA
Pinto, YM
Buikema, H
Grandjean, JG
Kingma, JH
Crijns, JHGM
van Gilst, WH
Citation: M. Oosterga et al., Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS study), AM J CARD, 87(5), 2001, pp. 542-546
Authors:
Oosterga, M
Voors, AA
Buikema, H
Pinto, YM
Haber, HE
Ebels, T
Morshuis, WJ
Kingma, JH
Crijns, HJGM
van Gilst, WH
Citation: M. Oosterga et al., Angiotensin II formation in human vasculature after chronic ACE inhibition: A prospective, randomized, placebo-controlled study, CARDIO DRUG, 14(1), 2000, pp. 55-60
Authors:
Pinto, YM
Bader, M
Pesquero, JB
Tschope, C
Scholtens, E
Van Gilst, WH
Buikema, H
Citation: Ym. Pinto et al., Increased kallikrein expression protects against cardiac ischemia, FASEB J, 14(13), 2000, pp. 1861-1863
Authors:
van Geel, PP
Pinto, YM
Voors, AA
Buikema, H
Oosterga, M
Crijns, HJGM
van Gilst, WH
Citation: Pp. Van Geel et al., Angiotensin II type 1 receptor A1166C gene polymorphism is associated withan increased response to angiotensin II in human arteries, HYPERTENSIO, 35(3), 2000, pp. 717-721
Authors:
Teisman, ACH
Buikema, H
van Veldhuisen, FJ
de Zeeuw, D
van Gilst, WH
Citation: Ach. Teisman et al., Direct vasodilating effects of the new dopaminergic agonist Z1046 in humanarteries, J CARDIO PH, 35(4), 2000, pp. 581-585
Authors:
Buikema, H
Monnink, SHJ
Tio, RA
Crijns, HJGM
de Zeeuw, D
van Gilst, WH
Citation: H. Buikema et al., Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure, BR J PHARM, 130(8), 2000, pp. 1999-2007
Authors:
Roks, AJM
van Geel, PP
Pinto, YM
Buikema, H
Henning, RH
de Zeeuw, D
van Gilst, WH
Citation: Ajm. Roks et al., Angiotensin-(1-7) is a modulator of the human renin-angiotensin system, HYPERTENSIO, 34(2), 1999, pp. 296-301
Authors:
Teisman, ACH
Pinto, YM
Buikema, H
Flesch, M
Bohm, M
Paul, M
van Gilst, WH
Citation: Ach. Teisman et al., Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats, J HYPERTENS, 16(12), 1998, pp. 1759-1765
Risultati:
1-11
|